All sessions are included in your registration fee.
Thursday, April 9
Professor of Psychiatry, Neurology, and Radiology
Dorothy C. Fuqua Chair, Psychiatric Neuroimaging and Therapeutics
Emory University School of Medicine
Helen Mayberg leads a multidisciplinary research program that studies brain mechanisms mediating depression pathogenesis and antidepressant treatment response using neuroimaging. She pioneered the development of deep brain stimulation for treatment-resistant depression. Her current projects emphasize development of novel imaging biomarkers that predict treatment response and optimal treatment selection for individual depressed patients at all stages of illness.
In recognition of her high-impact research, Dr. Mayberg is one of Emory University’s Game Changers. Her work has been heralded as one of the first hypothesis-driven treatment strategies for a major mental illness.
Dr. Mayberg is a board-certified neurologist, trained at the Neurological Institute of New York at Columbia University Medical Center and a postdoctoral fellowship in nuclear medicine at The Johns Hopkins medical institutions. She received an MD from the University of Southern California and a BA in psychobiology from the University of California, Los Angeles.
9:00 am–12:30 pm
Diego Pizzagalli, PhD
Harvard Medical School
William Carlezon, PhD
Michelle Craske, PhD
University of California, Los Angeles
Judy Garber, PhD
Vanderbilt University School of Medicine
Andrew D. Krystal, MD
Francis Lee, MD, PhD
Payne Whitney Manhattan
Daniel Pine, MD
National Institute of Mental Health